经皮给药草药精油通过调节代谢和肠道微生物群减轻高脂肪饮食引起的肥胖。

IF 4.4 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Frontiers in Pharmacology Pub Date : 2025-03-19 eCollection Date: 2025-01-01 DOI:10.3389/fphar.2025.1565030
Zu-Wen Ye, Qi-Yue Yang, Dong-Hua Yang, Qiao-Hong Lin, Xiao-Xia Liu, Feng-Qin Li, Fang-Fang Yan, Ping Luo, Si Qin, Fang Wang
{"title":"经皮给药草药精油通过调节代谢和肠道微生物群减轻高脂肪饮食引起的肥胖。","authors":"Zu-Wen Ye, Qi-Yue Yang, Dong-Hua Yang, Qiao-Hong Lin, Xiao-Xia Liu, Feng-Qin Li, Fang-Fang Yan, Ping Luo, Si Qin, Fang Wang","doi":"10.3389/fphar.2025.1565030","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Obesity, a global health challenge, is characterized by excessive fat accumulation and associated metabolic disorders. The ZhiZhu decoction, a traditional Chinese herbal formula consisting of <i>Citrus aurantium</i> L. (ZS, ZhiShi in Chinese) and <i>Atractylodes macrocephala Koidz</i> (BZ, Baizhu in Chinese), is widely recognized in clinics for its gastrointestinal regulatory effects.</p><p><strong>Methods: </strong>The chemical composition of ZS-BZ essential oil (ZBEO) was characterized using gas chromatography-mass spectrometry (GC-MS). Concurrently, we conducted <i>in vitro</i> investigations using HepG2 hepatoma cells to evaluate its anti-lipid deposition potential. To further elucidate the anti-obesity mechanisms, an <i>in vivo</i> model was established through high-fat diet (HFD)-induced obese rats, followed by transdermal ZBEO administration. Systemic analyses were performed integrating serum metabolomic profiling via UPLC-QTOF-MS and gut microbiota dynamics assessment through 16S rRNA gene sequencing.</p><p><strong>Results: </strong>ZBEO, rich in atractylon, D-limonene, and γ-elemene and shown to reduce lipid accumulation. Transdermal ZBEO administration in obese rats led to significant weight loss and improved serum metabolic indexes related to the POMC/CART signaling pathway. Additionally, ZBEO altered gut microbiota, enhancing beneficial bacteria and affecting metabolic pathways linked to obesity.</p><p><strong>Discussion: </strong>We discovered that ZBEO exerts a significant influence on obesity by modulating key biological processes, including glucose metabolism, lipid metabolism, and the composition of gut microbiota.</p>","PeriodicalId":12491,"journal":{"name":"Frontiers in Pharmacology","volume":"16 ","pages":"1565030"},"PeriodicalIF":4.4000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962428/pdf/","citationCount":"0","resultStr":"{\"title\":\"Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota.\",\"authors\":\"Zu-Wen Ye, Qi-Yue Yang, Dong-Hua Yang, Qiao-Hong Lin, Xiao-Xia Liu, Feng-Qin Li, Fang-Fang Yan, Ping Luo, Si Qin, Fang Wang\",\"doi\":\"10.3389/fphar.2025.1565030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Obesity, a global health challenge, is characterized by excessive fat accumulation and associated metabolic disorders. The ZhiZhu decoction, a traditional Chinese herbal formula consisting of <i>Citrus aurantium</i> L. (ZS, ZhiShi in Chinese) and <i>Atractylodes macrocephala Koidz</i> (BZ, Baizhu in Chinese), is widely recognized in clinics for its gastrointestinal regulatory effects.</p><p><strong>Methods: </strong>The chemical composition of ZS-BZ essential oil (ZBEO) was characterized using gas chromatography-mass spectrometry (GC-MS). Concurrently, we conducted <i>in vitro</i> investigations using HepG2 hepatoma cells to evaluate its anti-lipid deposition potential. To further elucidate the anti-obesity mechanisms, an <i>in vivo</i> model was established through high-fat diet (HFD)-induced obese rats, followed by transdermal ZBEO administration. Systemic analyses were performed integrating serum metabolomic profiling via UPLC-QTOF-MS and gut microbiota dynamics assessment through 16S rRNA gene sequencing.</p><p><strong>Results: </strong>ZBEO, rich in atractylon, D-limonene, and γ-elemene and shown to reduce lipid accumulation. Transdermal ZBEO administration in obese rats led to significant weight loss and improved serum metabolic indexes related to the POMC/CART signaling pathway. Additionally, ZBEO altered gut microbiota, enhancing beneficial bacteria and affecting metabolic pathways linked to obesity.</p><p><strong>Discussion: </strong>We discovered that ZBEO exerts a significant influence on obesity by modulating key biological processes, including glucose metabolism, lipid metabolism, and the composition of gut microbiota.</p>\",\"PeriodicalId\":12491,\"journal\":{\"name\":\"Frontiers in Pharmacology\",\"volume\":\"16 \",\"pages\":\"1565030\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962428/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fphar.2025.1565030\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fphar.2025.1565030","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

肥胖症是一项全球性的健康挑战,其特征是脂肪过度积累和相关的代谢紊乱。枳实汤是一种由枳实和白术组成的传统中药配方,具有胃肠调节作用,在临床上得到广泛认可。方法:采用气相色谱-质谱联用技术(GC-MS)对ZS-BZ精油(ZBEO)的化学成分进行表征。同时,我们利用HepG2肝癌细胞进行了体外研究,以评估其抗脂质沉积的潜力。为了进一步阐明抗肥胖机制,我们通过高脂饮食(HFD)诱导的肥胖大鼠建立了体内模型,然后经皮给药ZBEO。通过UPLC-QTOF-MS进行血清代谢组学分析,通过16S rRNA基因测序进行肠道微生物群动力学评估,进行系统分析。结果:ZBEO富含白术酮、d -柠檬烯和γ-榄香烯,具有降低脂质堆积的作用。肥胖大鼠经皮给药ZBEO可显著减轻体重,改善POMC/CART信号通路相关的血清代谢指标。此外,ZBEO改变了肠道微生物群,增强了有益菌群,并影响了与肥胖相关的代谢途径。讨论:我们发现ZBEO通过调节关键的生物过程,包括葡萄糖代谢、脂质代谢和肠道微生物群的组成,对肥胖产生显著影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota.

Introduction: Obesity, a global health challenge, is characterized by excessive fat accumulation and associated metabolic disorders. The ZhiZhu decoction, a traditional Chinese herbal formula consisting of Citrus aurantium L. (ZS, ZhiShi in Chinese) and Atractylodes macrocephala Koidz (BZ, Baizhu in Chinese), is widely recognized in clinics for its gastrointestinal regulatory effects.

Methods: The chemical composition of ZS-BZ essential oil (ZBEO) was characterized using gas chromatography-mass spectrometry (GC-MS). Concurrently, we conducted in vitro investigations using HepG2 hepatoma cells to evaluate its anti-lipid deposition potential. To further elucidate the anti-obesity mechanisms, an in vivo model was established through high-fat diet (HFD)-induced obese rats, followed by transdermal ZBEO administration. Systemic analyses were performed integrating serum metabolomic profiling via UPLC-QTOF-MS and gut microbiota dynamics assessment through 16S rRNA gene sequencing.

Results: ZBEO, rich in atractylon, D-limonene, and γ-elemene and shown to reduce lipid accumulation. Transdermal ZBEO administration in obese rats led to significant weight loss and improved serum metabolic indexes related to the POMC/CART signaling pathway. Additionally, ZBEO altered gut microbiota, enhancing beneficial bacteria and affecting metabolic pathways linked to obesity.

Discussion: We discovered that ZBEO exerts a significant influence on obesity by modulating key biological processes, including glucose metabolism, lipid metabolism, and the composition of gut microbiota.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Pharmacology
Frontiers in Pharmacology PHARMACOLOGY & PHARMACY-
CiteScore
7.80
自引率
8.90%
发文量
5163
审稿时长
14 weeks
期刊介绍: Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信